Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus Erythematosus and Chronic Obstructive Pulmonary Disease.
作者:
主题词
成年人(Adult);活组织检查(Biopsy);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);红斑狼疮, 系统性(Lupus Erythematosus, Systemic);男(雄)性(Male);浆细胞(Plasma Cells);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive);硬皮病, 系统性(Scleroderma, Systemic);疾病严重程度指数(Severity of Illness Index);皮肤(Skin);治疗结果(Treatment Outcome)
DOI
10.1002/art.40656
PMID
29956883
发布时间
2019-12-10
- 浏览4

Arthritis & rheumatology (Hoboken, N.J.)
2018年70卷12期
2087-2095页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文